Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment. We aimed to identify potential biomarkers that can predict invasiveness risk. | Potential biomarkers of ductal carcinoma in situ progression